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RESEARCH ARTICLE
Neuroinflammatory Gene Expression Alterations in Anterior Cingulate
Cortical White and Gray Matter of Males With Autism Spectrum
Disorder
Aubrey N. Sciara, Brooke Beasley, Jessica D. Crawford, Emma P. Anderson, Tiffani Carrasco, Shimin Zheng,
Gregory A. Ordway, and Michelle J. Chandley
Evidence for putative pathophysiological mechanisms of autism spectrum disorder (ASD), including peripheral inflamma-
tion, blood–brain barrier disruption, white matter alterations, and abnormal synaptic overgrowth, indicate a possible
involvement of neuroinflammation in the disorder. Neuroinflammation plays a role in the development and maintenance
of the dendritic spines involved in glutamatergic and GABAergic neurotransmission, and also influences blood–brain per-
meability. Cytokines released from microglia can impact the length, location or organization of dendritic spines on excit-
atory and inhibitory cells as well as recruit and impact glial cell function around the neurons. In this study, gene expression
levels of anti- and pro-inflammatory signaling molecules, as well as oligodendrocyte and astrocyte marker proteins, were
measured in both gray and white matter tissue in the anterior cingulate cortex from ASD and age-matched typically devel-
oping (TD) control brain donors, ranging from ages 4 to 37 years. Expression levels of the pro-inflammatory gene, HLA-DR,
were significantly reduced in gray matter and expression levels of the anti-inflammatory gene MRC1 were significantly ele-
vated in white matter from ASD donors as compared to TD donors, but neither retained statistical significance after correc-
tion for multiple comparisons. Modest trends toward differences in expression levels were also observed for the pro-
inflammatory (CD68, IL1β) and anti-inflammatory genes (IGF1, IGF1R) comparing ASD donors to TD donors. The direction
of gene expression changes comparing ASD to TD donors did not reveal consistent findings implicating an elevated pro- or
anti-inflammatory state in ASD. However, altered expression of pro- and anti-inflammatory gene expression indicates some
involvement of neuroinflammation in ASD. Autism Res 2020, 13: 870–884. © 2020 The Authors. Autism Research publi-
shed by International Society for Autism Research and Wiley Periodicals LLC
Lay Summary: The anterior cingulate cortex is an integral brain region in modulating social behaviors including nonverbal
communication. The study found that inflammatory gene expression levels were altered in this brain region. We hypothe-
size that the inflammatory changes in this area could impact neuronal function. The finding has future implications in
using these molecular markers to identify potential environmental exposures and distinct cell differences in autism.
Keywords: autism; pathology; cytokines; neuroinflammation; white matter; postmortem
Introduction
Autism spectrum disorder (ASD) is a neurodevelopmental
disorder that impacts social communication, emotional
response and can result in repetitive or restrictive behav-
iors. Currently, ASD has a prevalence of one in 59 chil-
dren with higher rates reported in males of one in 42 and
is four times more likely to affect males than females
(CDC surveillance data). Regardless of diagnostic conse-
quences on prevalence, the financial impact of ASD is
profound including increased patient office visits, phar-
maceutical needs, and special education services across
the lifespan [Buescher, Cidav, Knapp, & Mandell, 2014;
Lavelle et al., 2014; Zerbo et al., 2019]. Early behavioral
interventions are the only option for treating the core
features of ASD and have been shown to affect behavioral
outcomes [as reviewed by Zwaigenbaum et al., 2015]. The
lack of specific biomarkers coupled with the benefits of
early diagnosis sorely highlight the need to find a consis-
tent, specific and reliable pathophysiology associated
with the disorder that could lead to better diagnostic
capability and possible preventative measures.
A core behavioral feature of the disorder is the display
of atypical social actions that vary widely among those
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affected. Three important brain regions that contribute to
the social brain network include the amygdala, anterior cin-
gulate cortex (ACC), and the prefrontal cortical regions.
Social encounters result in the activation of excitatory neu-
rons in the amygdala to generate an action potential that
will travel to the ACC where yet another action potential
will elicit further downstream signaling in the prefrontal
cortex where cognitive planning steps are executed. The
series of action potentials are known to be part of the social
brain loop and can exhibit dynamic plasticity during devel-
opment [Blakemore, 2008]. Magnetic resonance imaging
studies, both resting (MRI) and functional (fMRI), have
been instrumental in determining that these areas are differ-
ent between typically developing (TD) and ASD patients
[Aylward et al., 1999; Gomot et al., 2006; Just, Cherkassky,
Keller, Kana, & Minshew, 2007; Rausch et al., 2016]. Addi-
tionally, all three regions have demonstrated a unique neu-
ropathology in ASD. In the amygdala, neuronal numbers
are reduced overall but in particular in the lateral nucleus
[Schumann & Amaral, 2006] while the microglia marker
IBA-1 was increased in the region [Morgan, Barger,
Amaral, & Schumann, 2014]. Prefrontal cortical areas have
been shown to have markers of neuronal overgrowth in
young children diagnosed with ASD when compared to TD
control brain tissue [Courchesne, Carper, & Akshoomoff,
2003; Hutsler & Zhang, 2010] while others have shown the
number of interneurons were decreased [Ariza, Rogers,
Hashemi, Noctor, & Martínez-Cerdeño, 2018; Hashemi,
Ariza, Rogers, Noctor, & Martínez-Cerdeño, 2016]. In the
ACC, decreased neuronal size and cell packing have been
reported in layers I–III [Simms, Kemper, Timbie, Bauman, &
Blatt, 2009] as well as a reduction in pyramidal cell size in
layer V and a correlation between Von Economo neurons
and ASD severity [Uppal et al., 2014]. Even when neuronal
abnormalities have not been identified, there have been
findings of columnar or laminar disorganization in cortical
regions [Casanova, Buxhoeveden, Switala, & Roy, 2002;
Trutzer, García-Cabezas, & Zikopoulos, 2019]. It is possible
that ASD neuronal pathology is the result of widely hetero-
geneous brain regional disconnections.
Concordance rates as high as 88% formales and 100% for
females were found in monozygotic twin studies [Rosen-
berg et al., 2009] suggesting that ASD has a strong genetic
contribution.Concordance rates of 30%have been reported
in dizygotic twins [Hallmayer et al., 2011] and 11% in sib-
lings with an additional one-fifth of siblings displaying lan-
guage delays [Constantino, Zhang, Frazier, Abbacchi, &
Law, 2010]. Additionally, de novo copy number variations
have been identified in ASD populations [Neale et al., 2012;
Sanders et al., 2012; Sebat et al., 2007] and approximately
35% of children diagnosed with ASD have a recognizable
genetic disorder or chromosomal deletion or duplication
[Schaefer, 2016]. Genetic syndromes including Rett’s syn-
drome, fragile X, and tuberous sclerosis complex (TSC 1/2)
are referred to as syndromic ASD if behaviors are present.
Interestingly, the syndromic disorders previously men-
tionedhave a unique single genemutation for each disorder
that is linked to the synaptic protein, mammalian target of
rapamycin or mTOR [Ricciardi et al., 2011; Sharma et al.,
2010; Tee et al., 2002]. The mTOR protein is responsible for
cell survival and dendritic plasticity and the association
with syndromic ASD suggests that mTOR may be impli-
cated in disrupted cell signaling in non-syndromic or idio-
pathic ASD.While no single unique gene has been found to
cause idiopathic autism, multiple autism susceptibility can-
didate genes have been identified [C Yuen et al., 2017;
Glessner et al., 2009]. But while the evidence for a genetic
etiology of ASD is strong, it has not yielded definitive results
nor explains the heterogeneity of the spectrum disorder
even though thousands of affected individuals and first-
order relatives have been sequenced. Environmental expo-
sures or events may trigger neurodevelopmental alterations
in utero or shortly thereafter making neuropathological
studies of ASD essential in identifying definitive targets for
etiological studies or therapeutic regimens.
A potential link between in utero or perinatal exposures
to existing identifiable neuropathology may lie in the
amount of inflammation that the brain is exposed to during
development. Human epidemiology studies have suggested
that maternal autoimmune disorders and situational envi-
ronmental exposures are associated with the development
of ASD [Atladottir, Henriksen, Schendel, & Parner, 2012;
Atladottir et al., 2009; Keil et al., 2010; Stevens, Nash,
Koren, & Rovet, 2013; Xiang et al., 2015]. Additionally,
associations between exposures to anti-seizure medications
[Christensen et al., 2013] and antidepressants [Harrington,
Lee, Crum, Zimmerman, & Hertz-Picciotto, 2014] to a
future ASD diagnosis have been found. A common thread
in the aforementioned exposure studies is the ability to
increase neuroinflammation in the fetal brain. The specific
cytokines and degree of affect may contribute greatly to the
wide heterogeneity of symptom presentation in the disor-
der. Interestingly, mothers with elevated IFNγ, IL-4, and IL-
5 cytokine levels [Goines et al., 2011] and those with
increased TNFɑ levels in amniotic fluid [Abdallah et al.,
2013] had an increased risk for an ASD diagnosis in the
child. These cytokines have the ability to cross the placental
and blood–brain barrier to trigger cytokine expression in
the brain.Microglia are the glial cell type responsible for reg-
ulating the majority of cytokine levels in extracellular areas
of neighboring neurons and astrocytes; therefore, if
microglia have been stimulated to release aberrant, local-
ized levels of cytokines then astrocytes would be one of the
first indicators by expressing the reactive protein GFAP that
has been shown bymultiple groups, including ours, inmul-
tiple brain regions in ASD [Crawford et al., 2015; Kotagiri,
Chance, Szele, & Esiri, 2014; Laurence& Fatemi, 2005]. Low
levels of extracellular cytokines work to provide the homeo-
static balance during neuronal signaling, but pathophysio-
logical levels of unknown amounts of cytokines identified
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in postmortem brain tissue may lead to inefficient synaptic
development and function in ASD. For example, excessive
levels of the cytokine, insulin-like growth factor 1 (IGF1),
demonstrated increased synaptic markers in both animal
and cell culture studies [Carlson et al., 2014; Cheng et al.,
2003; Corvin et al., 2012; Shcheglovitov et al., 2013] and
prevented neurodegeneration in mouse models of brain
injury [Madathil et al., 2013]. Conversely, increased levels
of TGFβ reduce the number of neurons in the dentate gyrus
of the hippocampus and result in social behavior deficits
[Depino, Lucchina, & Pitossi, 2011]. Hence, abnormal gene
expression levels associatedwith unique inflammatory phe-
notypes in postmortem brain tissue may offer clues regard-
ing neuropathophysiology inASD.
ASD is considered a spectrum disorder of atypical con-
nections between brain areas, causing deficits in speech,
motor skills, and social interaction. Most research to date
has focused on the role of neurons in ASD pathology,
while other major cell types in the brain have received far
less attention. In the past, our lab has investigated the
role of neurons and macroglia (astrocytes and oligoden-
drocytes) in ASD pathology, but not microglia. As the
immune cells for the central nervous system (CNS),
microglia can not only protect the brain from pathogenic
factors and preserve homeostatic conditions via synaptic
pruning and phagocytosis of apoptotic neurons but can
also increase spine densities necessary for neurotransmis-
sion. Microglia are differentiated into distinct phenotypes
that are associated with pro-inflammatory and anti-
inflammatory responses. Pro-inflammatory microglial
responses produce cytokines and assume phagocytic roles
that promote defense mechanisms, digest neurons and
prune dendritic trees. In contrast, anti-inflammatory
microglial responses facilitate CNS healing by participat-
ing in phagocytosis, neuronal remodeling, and tissue
regeneration. However, altered expression levels of either
phenotype could have detrimental effects on neurotrans-
mission. It is imperative to characterize and determine
the potential contributory role of pro- and anti-
inflammatory mediators in the pathology of ASD.
Hypothesis
Given the growing evidence of a role of neuroinflam-
mation in ASD, the present study was undertaken to
examine the levels of gene expression of markers of
inflammation in anterior cingulate cortical tissues from
brain donors that had ASD and from typically develop-
ing, age-matched donor tissue. The ACC was chosen
because of the relationship to the amygdala and frontal
cortex in the social behavior brain region network. Gene
expression markers for two major glia cell types, astro-
cytes and oligodendrocytes, which respond to cytokine
receptor activation, were included in this study.
Methods and Materials
Brain Tissue
Flash-frozen postmortem BA24 tissue blocks from ASD
donors and typically developed control donors were
acquired from Autism BrainNet, a resource of the Simons
Foundation Autism Research Initiative (additionally houses
tissue from the Autism Tissue Program, Harvard Brain Tis-
sue Resource Center, Belmont,MA) and Neurobiobank (for-
merly NICHD Brain and Tissue Bank for Developmental
Disorders, Baltimore, MD). This study was reviewed by the
Institutional Review Board of East Tennessee State Univer-
sity, who determined that it does not constitute human
research under the Department of Health and Human Ser-
vices exemption 45 CFR 46.101(b) relating to the use of
publicly available unidentifiable pathology specimens. ASD
(N = 17) and control donors (N = 17) were matched prior to
experimentation by gender, age, and RNA quality. Control
donors died by trauma (4), drowning (3), asphyxia (3), heart
attack (2), respiratory issues (2), dilated cardiomyopathy (1),
commotio cordis (1), and an unknown cause (1). ASD
donors died by trauma (4), respiratory issues (3), asphyxia
(2), cardiac arrhythmia (2), cardiopulmonary arrest (2),
bowel obstruction (1), cancer (1), congestive heart failure
(1), and diabetic ketoacidosis (1). Age and RNA quality were
matched as closely as possible with a difference of no more
than 3 years in age and one RNA integrity number for
almost every ASD and control donor pair (Table 1). ASD
donors were diagnosed using the Autism Diagnostic
Interview-Revised (ADI-R) and met the diagnostic criteria
outlined in the Diagnostic and Statistical Manual IV for
autistic disorder. For the protection of the identity of the
ASD and control subjects, causes of deathwere not incorpo-
rated in Table 1.
Tissue Preparation and Sectioning
Frozen BA24 tissue was sectioned at thicknesses of 50 μm
at −20C using a cryostat microtome (Leica CM3050S) for
differential gene expression analysis and immunohisto-
chemical identification, respectively. To avoid cross-
contamination between subjects, the internal elements of
the microtome were cleaned using 100% ethanol. Tissue
sections from subject pairs were prepared on the same
day to guarantee equal storage time. Gray matter punches
were obtained by a placing the maximum diameter of a
disposable 3.5 mm trephine tool at layer three of the neo-
cortex. Superficial white matter was punch-dissected at
approximately 2 mm past the discernable neocortical
layer VI. Dissected tissues were stored at −80C and were
later homogenized for RNA isolation.
RNA and cDNA Preparation
Total RNA was isolated from the laser capture
microdissected (LCM) white matter using a Maxwell
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16 LEV simplyRNA Tissue Kit (Promega, Madison, WI).
To minimize tissue usage in future extractions, a
Direct-zol RNA MicroPrep Kit (Zymo Research, Irvine,
CA) was used to extract total RNA from the gray mat-
ter and white matter punches for the analysis of the
expression of the remaining genes. The RNA quality
was assessed by measuring RNA integrity number
(RIN) values with the Bioanalyzer RNA 6000 Nano
chip (Agilent Technologies, Santa Carla, CA) and the
Agilent 2200 TapeStation (Agilent Technologies),
respectively. Double-stranded cDNA was made by
reverse transcription of the RNA samples using the
Superscript III kit (Life Technologies, Grand Island,
NY) that utilized both oligodTs and random hexamer
primers during synthesis. Each cDNA reaction was
standardized to 250 ng of input RNA.
Table 1. Subject Demographics Information for Postmortem Brain Tissue That was Used in the Study




1 AN14757 24 M 7.8 21.33 Frozen WM
2 AN07176 21 M 7.6 29.91 Frozen WM, GM
3 AN07444 17 M 6.1 30.75 Sertraline Frozen WM
4 5408 6 M 5.8 16 Frozen WM
5 4848 16 M 7.5 15 Frozen WM, GM
6 5342 22 M 8.0 14 Frozen WM, GM
7 5079 33 M 5.3 16 Ethanol Frozen WM, GM
8 M3231M 37 M 4.9 24 Frozen WM, GM
9 AN12137 31 M 4.5 32.92 Frozen WM, GM
10 AN03217 19 M 5.3 18.58 Frozen WM, GM
11 AN00544 17 M 5.8 28.92 Frozen WM, GM
12 AN17425 16 M 6.8 26.16 Frozen WM, GM
13 4590 20 M 6.8 19 Frozen WM, GM




5.7 15 Montelukast, Albuterol,
Prednisone, Loratidine Frozen GM
18 1105 16 M 7.8 17 Frozen GM
19 4334 12 M 5.7 15 Frozen GM
Mean 19.24 6.3 20.97
SEM 2.12 0.3 1.56
ASD
1 AN04166 24 M 8.1 18.51 Frozen WM
2 AN03935 19 M 7.0 28 Frozen WM, GM
3 AN02987 15 M 6.7 30.83 Frozen WM




4.8 20 Risperidone, Fluvoxamine,
Clonidine, Insulin Frozen WM, GM




2.5 50 Quetiapine, Fluoxetine,
Divalproex Sodium, ziprasidone Frozen WM, GM
8 5027 37 M 4.7 26 Risperidone, Fluvoxamine Frozen WM, GM
9 AN11989 30 M 5.7 16.06 Frozen WM, GM
10 AN07817 19 M 4.5 14.83 Frozen WM, GM
11 AN00764 20 M 5.9 23.66 Minocycline Frozen WM, GM
12 AN04682 15 M 5.6 23.23 Frozen WM, GM
13 4999 20 M 7.0 14 Frozen WM, GM
14 5308 4 M 7.0 21 Frozen WM, GM
17 5565 12 M 7.0 22 Frozen GM
18 5403 16 M 6.6 35 Frozen GM
19 5334 11 M 5.1 15 Frozen GM
Mean 18.88 6.0 22.30
SEM 2.11 0.3 2.48
P-valuea 0.906 0.403 0.654
ID, identification number; RIN,, RNA integrity number; PMI,, postmortem interval; qPCR,, quantitative real-time polymerase chain reaction; WM,, white
matter; GM,, gray matter.
aP-value = results of an independent t-test comparing control and ASD groups, statistically significant when P < 0.05.
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Polymerase Chain Reactions
For primer temperature and cycle number optimization,
end-point polymerase chain reaction (PCR) was per-
formed using a T100 Thermo Cycler (Bio-Rad, Hercules,
CA). Each reaction contained SYBR Green Master Mix
(Qiagen, Valencia, CA), cDNA template, and gene-specific
primers (sequences shown in Table S1). Gene expression
results from LCM white matter and white matter punches
were compared by quantitative real-time polymerase
chain reaction (qPCR) to determine which tissue isolation
technique ultimately yielded sufficient amounts of RNA
for the gene expression studies. Once determined, qPCR
was performed for genes. Information for genes used for
normalization (GAPDH, TBP), glial activation (GFAP,
MOG), pro-inflammatory (CD68, HLADR, IL1B, NOS2),
and anti-inflammatory markers (ARG1, IGF1, IGF1R,
MRC1, PPARγ, VDR) are shown in Table 2. Each PCR reac-
tion was performed in triplicate with pairs of tissue repre-
sented on the plate if multiple plates were used to collect
data for each gene.
Statistical Analysis
Expression data for target genes were normalized to refer-
ence genesGAPDH and TBP. Fold changes in the expression
of genes of interest comparing ASD to control subjects were
obtained using the 2−ΔΔCt method [Livak & Schmittgen,
2001]. Median Ct values were used for the final calculations
for all genes. For these calculations, the geometric means of
Ct values of reference genes were used for normalizations.
Outliers in data sets were identified and removed using
robust regression and outlier removal (ROUT; GraphPad
Prism v.8 for macOS). Gene expression levels from control
and ASD donors were compared using independent t-tests,
with equality of variances analyzed using the Levene’s test
[SPSS (version 24, IBM, New York, NY)]. Potentially con-
founding effects of age, RIN values, and postmortem inter-
vals (PMIs), on gene expression levels were considered by
computing Pearson correlations (GraphPad Prism v.8;
Tables S2 and S3). When correlations between potentially
confounding factors and gene expression levels reached a
level of significance of P < 0.01, then those data were
Table 2. Reference Genes, Glial Markers, Pro-Inflammatory Microglial Markers, and Anti-Inflammatory Microglial Markers Used
For Gene Expression Studies
Gene name Alias Protein name Brief description of function
Reference genes
GAPDH Glyceraldehyde-3-phosphate dehydrogenase GAPDH Catalyzes an energy-yielding step in glycolysis
TBP TATA-box binding protein TBP Transcription factor
Glial marker genes
GFAP Glial fibrillary astrocytic protein GFAP
Intermediate cellular filament that can be used to
identify astrocytes
MOG Myelin oligodendrocyte protein MOG
Component of the myelin sheath that encases neuronal
axons; used to identify oligodendrocytes
Pro-inflammatory microglial markers
CD68 Cluster of differentiation 68 CD68




class II, DR alpha chain HLA-DRA
Presents peptide antigens that are able to create an
immune response
IL1β Interleukin 1 beta IL1β
Cytokine mediator in inflammatory responses and
involved in cell proliferation, differentiation, and
apoptosis
NOS2 Nitric oxide synthase 2 iNOS
Enzyme that generates nitric oxide (reactive free
radical)
Anti-inflammatory microglial markers
ARG1 Arginase 1 ARG1
Enzyme that converts arginine into compounds used for
wound repair and downregulates nitric oxide
IGF1 Insulin-like growth factor 1 IGF1
Ligand that stimulates proliferation of oligodendrocytes
(supports myelination of neuronal axons)
IGF1R Insulin-like growth factor 1 receptor IGF1R
Tyrosine kinase cell surface receptor that binds with
IGF1
MRC1 Mannose receptor, C type 1 CD206
Receptor that binds and internalizes mannosylated
ligands on potentially pathogenic microorganisms so




Receptor that inhibits pro-inflammatory gene
expression
VDR Vitamin D Receptor VDR
Receptor found on the nucleus that binds to calcitriol,
the active form of Vitamin D
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reanalyzed using the significant confounder as a covariate
in the analysis (as noted). Because multiple t-tests were per-
formed, statistics are reported before and after Holm-
Bonferroni correction [Gaetano, 2013; Holm, 1979] for the
number of gene comparisons (Tables 3 and 4).
Results
Sample Characterization
There were no statistical differences between the ASD and
TD group regarding age, RIN, and PMI (Table 1). Addition-
ally, no significant differences in the expression levels of
housekeeping genes GAPDH and TBP were observed com-
paring ASD to TD donors (Fig. 1). Levels of GFAP and MOG
were measured to determine if glia activation could be
identified by elevated gene expression in the ACC of the
ASD group. Both MOG and GFAP were not significantly
changed in ACC gray matter from ASD compared to TD
donors (Fig. 2A; Table 3). Gene expression levels for both glia
geneswere unchanged in thewhitematter (Fig. 2B; Table 4).
Pro-Inflammatory Related Cytokine Gene Expression
The expression levels of the pro-inflammatory-related
genes HLA-DR, IL1β, CD68 (gray only), and NOS2 were
analyzed in gray and white matter from ASD and TD con-
trol donors (Fig. 3). Initial analysis of HLA-DR expression
levels in gray matter demonstrated significant correla-
tions with age and PMI (Table S2). An analysis of variance
with RIN and PMI as covariates indicated that HLA-DR
expression was significantly reduced in gray matter of
Table 3. Results of Independent t-Tests for Comparison of Gray Matter Gene Expressions in Controls and ASD Brain Donors
Gene Sample size (control, ASD) t value (or F as noted) df P P0 a
Reference genesb 17, 17 0.886 32 0.382 1.000
GFAP 12, 10 0.391 20 0.700 1.000
MOG 13, 12 −1.573 20 0.129 1.000
HLDAR 13, 11 3.312c 1 0.040 0.520
IL1β 11, 11 −1.581d 10.2 0.144 1.000
CD68 13, 10 1.951 21 0.065 0.756
NOS2 11, 11 0.42 20 0.679 1.000
IGF1 15, 15 1.356 28 0.186 1.000
IGF1R 14, 14 3.823c 1 0.063 0.756
VDR 13, 14 −1.073 25 0.293 1.000
ARG1 12, 13 −0.632 23 0.534 1.000
MRC1 14, 15 0.093 27 0.926 1.000
PPARγ 13, 13 −0.111 24 0.913 1.000
aP-value corrected by Holm–Bonferroni Sequential Correction for multiple comparisons.
bComparison of the deltaCt values of TBP and GAPDH gene expression for control and ASD donors.
cValues of statistic shown reflect results of analysis of covariance based on significant correlations (P < 0.01) identified for age, PMI, or RINH (see
Table S2).
dStatistics shown were calculated assuming unequal variances base on results of the Levene’s test for equality of variances.
Table 4. Results of Independent t-Tests for Comparison of White Matter Gene Expressions in Controls and ASD Brain Donors
Gene Sample size (control, ASD) t value (or F as noted) df P P0 a
Reference genesb 15, 14 1.458 27 0.156 1.000
GFAP 10, 9 0.006 17 0.995 1.000
MOG 10, 9 1.526c 1 0.235 1.000
HLDAR 10, 9 −0.059 17 0.954 1.000
IL1β 12, 12 −1.971d 12.7 0.071 0.726
NOS2 10, 9 0.218 17 0.830 1.000
IGF1 13, 12 −1.935d 12.3 0.076 0.726
IGF1R 11, 11 −0.156 20 0.878 1.000
VDR 11, 10 3.822c 1 0.066 0.726
ARG1 8, 9 −0.667 15 0.515 1.000
MRC1 12, 13 −2.827 23 0.010 0.120
PPARγ 10, 9 −0.990 17 0.336 1.000
aP-value corrected by Holm–Bonferroni Sequential Correction for multiple comparisons.
bComparison of the deltaCt values of TBP and GAPDH genes from control and ASD donors.
cValues of statistics shown reflect results of analysis of covariance based on significant correlations identified for age, RIN, or PMI (see Table S3).
dStatistics shown were calculated assuming unequal variances base on results of the Levene’s test for equality of variances.
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ASD donors (P = 0.04; Fig. 3A); however, significance was
lost after a Holm–Bonferroni correction for multiple com-
parisons was applied (Table 3). IL1β was modestly ele-
vated in ACC white matter from ASD donors (P = 0.07;
Fig. 3B; Table 4), while gray matter IL1β expression levels
in gray matter showed the same trend (Table 4) with nei-
ther reaching statistical significance. CD68 expression
levels in gray matter significantly correlated with RIN and
PMI (Table S2) and covariate analysis of variance revealed
a P-value of 0.06 for the comparison of ASD to TD donors
(Fig. 3A; Table 3). CD68 expression was not measured in
white matter. No trending differences in NOS2 expression













Figure 1. Difference between the Ct values of the two reference
genes TBP and GAPDH in both gray (n = 17) and white matter
(n = 14) using quantitative real-time PCR. No significant differ-

































Gray Matter White MatterA B
Figure 2. Panel A is real-time quantitative PCR analysis of MOG (n = 13) and GFAP (n = 12) in gray matter using punch-dissected ante-
rior cingulate tissue centered at layer III from age-matched pairs of male donor tissue from typically developing controls (unfilled bars)
and males diagnosed with ASD (filled bars). Target gene expression was normalized to the geometric mean of TBP and GAPDH. Relative
gene expression levels that were significant or close to significant are shown as fold changes using the Livak and Schmittgen method
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Figure 3. Real-time quantitative polymerase chain reaction of pro-inflammatory marker genes HLADR (n = 13), IL1β (n = 11), CD68
(n = 13), and NOS2 (n = 11) in gray matter shown in panel A with unfilled bars representing typically developing (TD) control donor tis-
sue and filled bars representing ASD donor tissue punch-dissected from layer III of the neocortex in gray matter. Panel B represents pro-
inflammatory related gene expression of HLADR (n = 10), IL1β (n = 12), and NOS2 (n = 10) in punch-dissected superficial ACC white mat-
ter of TD and ASD donors. Relative gene expression was normalized to the geometric mean of TBP and GAPDH shown as fold changes
using the Livak and Schmittgen method [Livak & Schmittgen, 2001].
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Anti-Inflammatory Related Cytokine Gene Expression
The level of expression of genes related to anti-
inflammatory mechanisms, including IGF1, IGF1R, VDR,
ARG1, MRC1, and PPARγ were analyzed in white and gray
matter from ASD and TD donors (Fig. 4). Expression levels
for IGF1R demonstrated significant correlations with RIN
and PMI (Table S2) in gray matter and covariate analysis of
variance revealedmodestly lower levels of IGF1R expression
in gray matter from ASD donors as compared to TD donors
(P = 0.06, Fig. 4A; Table 3). In white matter, both IGF1
(P = 0.08; Table 4) andVDR (P = 0.07; Table 4) demonstrated
trends for elevated expression levels in ASD donors but did
not make statistical significance. MRC1 expression levels
were significantly elevated in white matter from ASD
donors (P = 0.01; Fig. 4B; Table 4), but significance was lost
upon application of the Holm–Bonferroni correction factor
(Table 4). ARG1 and PPARγ did not demonstrate any differ-
ences in gene expression in gray or white matter comparing
ASD to control donors.
Discussion
Within the field of ASD research, pathology studies using
postmortem brain tissues have been mainly limited to
examining brain areas as a whole, without considering
potential differences in white and gray matter. It is known
that microglia reside in both white and gray matter; how-
ever, it is still unclear whether there is a difference in the
functions of microglia that exist in white as compared to
those that occur in gray matter [McKay, Brooks, Hu, &
McLachlan, 2007]. The present research is one of the few
studies that has characterizedmicroglial phenotype-specific
gene expression levels in both white and gray matter brain
tissue in ASD. Altered gene expression levels in both pro-
inflammatory and anti-inflammatory markers in ACC from
donors with ASD, when compared to TD controls, is the pri-
maryfinding of this study.
Impaired neuronal communication likely through
altered synaptic plasticity is considered a core neuropatho-
physiological feature of ASD. The pro-inflammatory cyto-
kine IL1β has a well-documented history with neuronal
synapse modulation. For example, early studies indicate
that IL1β is necessary for long-term potentiation in hippo-
campalCA1as shown through IL1-R (interleukin1 receptor)
knock-out [Avital et al., 2003] and pharmacological
methods [Coogan, O’Neill, & O’Connor, 1999; Schmid,
Lynch, & Herron, 2009] in animals. Increases in IL1β gene
expression follow long-term potentiation (LTP) induction
[Schneider et al., 1998] and ultimately inhibit excitatory
synaptic transmission [Yang et al., 2005]. IL1β likely modu-
lates LTP through changes in calcium conductance by way
of the glutamate receptor family, NMDAR [Coogan &
O’Connor, 1997; Gardoni et al., 2011; Viviani et al., 2003].
Very few findings have evaluated the impact of IL1β neu-
roinflammation on BDNF signaling in neurons. It has been
shown using rat hippocampal slices that IL1β interferes
with BDNF downstream signaling [Tong et al., 2012] and
prevents the formation of dendritic spines in neurons
[Tomasoni et al., 2017]. Additionally, IL1β interferes with
BDNF-induced cell survival specifically through mTOR sig-
naling pathway [Smith et al., 2014]. It is possible that
increases in IL1β impact synaptic signaling via BDNF in
ASD. In human ASD, increased plasma levels of IL1β have
been shown across the lifespan as reviewed by Saghazadeh
et al. [2019]. Interestingly, our laboratory has shown
changes in the gene expression levels of NMDAR receptors
as well as downregulation of the BDNF receptor NTRK2 in
ACC glutamatergic neurons in ASD as compared to cells






































Figure 4. Real-time polymerase chain analysis of anti-inflammatory
related genes IGF1 (n = 15), IGF1R (n = 14), VDR (n = 13), ARG1
(n = 12),MRC1 (n = 10), and PPARγ (n = 13) in ACC cortical gray matter
punch-dissected using layer three as the diameter in typically develop-
ing (TD) males (unfilled bars) and ASD donor tissue (filled bars) is
shown in panel A. Panel B represents anti-inflammatory related genes
IGF1 (n = 13), IGF1R (n = 11), VDR (n = 11), ARG1 (n = 8), MRC1
(n = 12), and PPARγ (n = 10) in ACC superficial white matter. Relative
gene expression was normalized to the geometric mean of TBP and
GAPDH and shown as fold changes using the Livak and Schmittgen
method [Livak & Schmittgen, 2001].
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Szebeni, & Ordway, 2015]. Although only trending toward
statistical significance in this study for these subjects,
altered levels of IL1β gene expression in human ASD brain
tissue may indicate that immunity may play a direct role in
etiology of the disorder.
Both CD-68 and HLADR are membranous proteins that
are associated with the pro-inflammatory microglia phe-
notype. The findings in this study indicate that CD-68
and HLA-DR gene expression might be altered in the
ACC (CD-68 was only trending and statistical corrections
eliminate the change in HLA-DR). CD-68 is associated
with the innate immune response by signaling phagocy-
tosis and debris clearance, while HLADR is associated
with the complement immunity system and serves as a
ligand for T-cell binding. A previous study has shown
that HLA-DR protein levels is increased in ASD postmor-
tem brain tissue [Vargas, Nascimbene, Krishnan,
Zimmerman, & Pardo, 2005] and increases in serum com-
plement cells were shown in blood from ASD patients
[Ahmad et al., 2018]. The reduction in the mRNA of these
molecules in this study would support that, at least at the
gene level, alterations in the complement expression in
the brain may result in synaptic hyperconnectivity as it
has been shown in animals through reductions or knock-
out of pro-inflammatory cytokines [Chu et al., 2010;
Weinhard et al., 2018]. Excessive hyperconnectivity of
synapses has been shown in mouse models of syndromic
ASD including fragile X, tuberous sclerosis, and 15q
duplication [Jawaid et al., 2018; Sato & Okabe, 2019;
Tang et al., 2014].
Unlike IL1β, MRC1 expression does not have a well-
defined relationship with neurotransmission. Our findings
indicate that MRC1 was elevated in ASD white matter,
although significance was not retained after the correcting
factor for multiple comparisons. Interestingly, MRC1
expression was originally identified on macrophages and
represented a shift from anti-inflammatory cells to active
phagocytotic macrophages. The most prolific and well-
characterized function of MRC1 is to identify and facilitate
ingestion of pathogens through binding tomannose found
on bacteria. However, the receptor can bind a plethora of
other molecules including oligosaccharides, glycoprotein
hormones, myeloperoxidases, and lysosomal hydrolases.
Binding to hydrolases and peroxidases indicates thatMRC1
expressing cells are involved with the end stages of neuro-
inflammatory cellular events, that is, removal of apoptotic
or necrotic cells. Mannose receptor activation can induce
intracellular signaling events to trigger cytokine production
of IL10 and other molecules that act to suppress the
immune response [Chieppa et al., 2003]. Conversely, it has
been shown through in vitro studies that IL10 can induce
MRC1 receptor expression in cultured microglia [Liu et al.,
2013; Makita, Hizukuri, Yamashiro, Murakawa, & Hayashi,
2015]. Evaluations using fluorescence activated cell sorting
and other cell sorting methods have demonstrated that in
human brain tissue there are subsets of microglia
populations with detectableMRC1 protein expression [Böt-
tcher et al., 2019; Galatro et al., 2017] and are considered
representatives of the anti-inflammatory microglial pheno-
type. Modulation of inflammatory levels by external envi-
ronmental or therapeutic exposures can influence the shift
in microglial phenotype. Dimethyl fumarate, used in the
treatment of multiple sclerosis (MS), was found to reduce
pro-inflammatory levels [Spencer, Crabtree-Hartman,
Lehmann-Horn, Cree, & Zamvil, 2015; Wilms et al., 2010]
and in vitro studies with the drug led to increased gene
expression of MRC1 [Han, Xiao, Zhai, & Hao, 2016;
Kronenberg et al., 2019]. Overall, elevations of MRC1 in
ASD tissue could indicate atypical levels of inflammation in
white matter that would impact cell signaling between
brain regions. Upregulation of MRC1 expression has been
shown to be neuroprotective in animal models of spinal
cord injuries [Ji et al., 2015; Stivers et al., 2017]. Interest-
ingly, it was shown that rats exposed to lipopolysaccharide
at postnatal day three demonstrated increased expression
levels of MRC1 protein that had significant impairments in
communication and cognitive functions [Pang et al., 2016].
While much information is lacking regarding the role of
MRC1-specific anti-inflammatory microglia in neurotrans-
mission,MRC1 could serve as a valuable target for future eti-
ology or therapeutic studies inASD.
Current clinical trials using treatments with IGF1 for idio-
pathic ASD, tuberous sclerosis, and Rett syndrome patients
are underway. Our study did not identify significant gene
expression changes for either the ligand (IGF1) or the recep-
tor (IGF1R). However, it is worth mentioning that we did
see trending elevations for IGF1 gene expression in ASD
white matter brain tissue as well as trending reductions in
the IGF1R gene expression in ASD gray matter when com-
pared to TD control tissue. IGF1 is a mitogenic factor imper-
ative for fetal brain development and growth. In the brain,
IGF1 encourages the differentiation and maturation of
oligodendrocytes, myelination, and neuronal survival.
IGF1 Knock-out mice display postnatal lethality, develop-
mental retardation, defects in organ systems, and infertility
[Liu, Yakar, & LeRoith, 2000] while overexpressing IGF1
protein in mice results in increased brain size and neuronal
numbers [Ye et al., 2004]. IGF1 binds tightly with the recep-
tor (IGF-1R), triggering the autophosphorylation of the
intracellular β-subunit kinase domain of IGF-1R to recruit
adaptor proteins and activate several pathways including
the MAP kinase and PI3-kinase/Akt pathways. Both the
MAP kinase and PI3-kinase/Akt pathways activate mTOR,
which through increasing the cap-dependent translation
initiation complex can increase mRNA translation to influ-
ence multiple developmental functions [Bondy & Cheng,
2004]. Interestingly, Faridar et al. [2014] reported increased
activation of the MAP kinase pathway in mice with ASD-
like social and behavioral deficits. Increases in IGF1 expres-
sion in the white matter could promote elevated mTOR
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activation. An upregulation of mTOR and its activity in
individuals with ASD would confirm a hypothesis made by
other researchers that mTOR is in fact upregulated in ASD,
causing an increase in unregulated protein synthesis [Chen,
Alberts, & Li, 2014; Sawicka & Zukin, 2012; Wang & Doer-
ing, 2013]. Additionally, elevated IGF1 expression may
reflect a compensatory mechanism of the brain in response
to altered neurotransmission in the ACC leading to the
decreased structural integrity of the ACC white matter that
result in deficits in cognitive processing. Increased prolifera-
tion and differentiation of oligodendrocytes by IGF1 would
in turn myelinate neuronal axons thereby increasing syn-
chronization between brain areas and white matter struc-
tural integrity. A pilot study involving nine children with
Phelan-McDermid syndrome, a related syndromic ASD,
reported an association between 3 months of IGF1 treat-
ment and substantial improvement in social impairment
and behavior [Kolevzon et al., 2014]. It is not possible at this
point to know whether IGF1 gene expression changes are
casual in the etiology of autism or a result of cellular pro-
cesses that are activated to correct deficits that have their
root causes in other pathophysiological mechanisms. With
the prevalence ofmyelinating oligodendrocytes in thewhite
matter, it is plausible that the demand for IGF1 in the white
matter of ASD individuals may be higher than in the gray
matter, consistent with ourfindings.
Amost interestingfinding of this study is the gene expres-
sion trends of specifically the anti-inflammatory related
gene expression changes in white matter. White matter has
exhibited a unique pathology in ASD. For example, diffusor
tensor imaging studies have shown that subjects with ASD
exhibit reduced fractional anisotropy in white matter areas
of brain areas associated with social behaviors, including
the ACC, than in TD control subjects [Barnea-Goraly et al.,
2004] and can be correlated with diagnostic phenotype
[Cheung et al., 2009; Noriuchi et al., 2010]. Our own labora-
tory found increased GFAP protein in white matter
[Crawford et al., 2015] that could be related to elevated cyto-
kine levels [Madathil et al., 2013]. Volumetric studies indi-
cate that white matter volume is increased in ASD when
compared to TD control brains using postmortem and
imaging studies [as reviewed by Amaral, Schumann, &
Nordahl, 2008]. Lastly, myelin thickness was altered in
postmortem ASD donor tissue in white matter as compared
to TD donor tissue, with no change in oligodendrocyte
number and morphology [Zikopoulos & Barbas,
2010]. While white matter pathology exists in ASD, less
clear is the relationshipwith graymatter neocortical pathol-
ogy. Inmultiple sclerosis there is unique, discernable neuro-
nal pathology in the neocortical graymatter [as reviewed by
Lassmann, 2010], although the basis of the disease lies in
demyelination of axons in the white matter. Interestingly,
it was discovered in tumormetastatic studies that blood ves-
sels travel through the brain tissue to coil in the gray-white
matter junction known as the superficial or radial white
matter [Nonaka et al., 2003]. It is quite possible the inflam-
matory alterations are found in these areas of increased vas-
culature where they can alter myelination and ultimately
exhibit a discernable neuronal pathology that occurred dur-
ing critical developmental periods with a genetic suscepti-
bility leading to a multifactorial etiology with a
heterogeneous phenotypic presentation.
Limitations
The availability of postmortem ASD brain tissues is limited,
preventing us fromworking with larger sample sizes. For all
gene expression data, P-values were corrected for the num-
ber of comparisons of dependent variables (gene expres-
sions) using the Holm-Bonferroni correction. The corrected
P-value indicated no statistically significant difference
between ASD and control donors for gene expression in the
ACC (Tables 3 and 4). We attribute a lack of Holm-
Bonferroni adjusted significance of the expression levels to
our small sample size. Additionally, because of the limited
availability of tissues, some ASD and control donors
included in the studywere exposed tomedications (Table 1)
thatmight potentially influence the outcomes of this study.
Group donors were identified a priori by the brain banks
and variation between groupswas reduced asmuch as possi-
ble. Quantification of protein at a cellular level would give a
more definitive result; however, ASD donor tissue is an
extremely limited resource.
Conclusions
Genetic studies have introducedmany candidate genes that
have been identified in ASD and first-order relatives. It has
become apparent that one single gene is not responsible for
ASD, but rather many closely related genes in conjunction
with an environmental stimulus likely triggers alterations
that are found in social behavior brain areas. Postmortem
tissue is an important resource for the identification of
those transcriptomicmarkers that are associatedwith symp-
tom presentation or severity and will lead to mechanistic
studies to find causes or treatments for ASD. Our study was
able to identify alterations prior to statistical corrections of
specific cytokines and cell markers for glial activation in
a brain region associated with social behaviors. These
markers may be a key part of the relationship between
genome-wide studies, environmental exposures, and the
resulting neuropathologicalfindings in ASD.
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